Perlegen Sciences, Inc., a prominent player in the biotechnology industry, is headquartered in the United States. Founded in the early 2000s, the company has established itself as a leader in genomic research and personalised medicine, focusing on the development of innovative solutions for genetic analysis and drug discovery. With a strong emphasis on high-throughput genotyping and advanced bioinformatics, Perlegen Sciences offers unique services that cater to both academic and commercial sectors. Their cutting-edge technology enables researchers to unlock the complexities of the human genome, facilitating breakthroughs in disease understanding and treatment. Recognised for its contributions to the field, Perlegen Sciences has achieved significant milestones, positioning itself as a trusted partner in the life sciences community. The company continues to drive advancements in genomics, making a lasting impact on healthcare and research.
How does Perlegen Sciences, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Perlegen Sciences, Inc.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Perlegen Sciences, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Perlegen Sciences may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As such, the company does not inherit any emissions data from a parent organisation, nor does it participate in recognised climate frameworks like the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). Without specific emissions data or commitments, it is challenging to assess Perlegen Sciences' impact on climate change or its role in the broader industry context regarding sustainability efforts.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Perlegen Sciences, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.